Ticker brief
VRTX VERTEX PHARMACEUTICALS INC
Consumer, Non-cyclical · Biotechnology
last close
$541.69
1 day
-1.1%
14 days
+7.1%
mkt cap
$134.0B
signals 14d
19
authors 14d
16
crowd 14d
+1.6σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 33% mid · 62 pctile own 1y | IV/HV 0.86× (as of 2026-08-06) |
| Skew — 25Δ RR 30d | +0.021 99 pctile own 1y | calls bid vs puts (call skew rich) |
| Net dealer OI (NDOI) | +0.51 elevated | 5-session Δ +0.15 (as of 2026-07-06) |
| OI alarm | quiet | last alarm 2026-05-05 (z=2.1) |
Sentiment — last 14 days
daily mean sentiment, 2026-08-18 → 2026-08-28 · now +0.00 (−1 bearish … +1 bullish)
Who spoke16
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @TravisBiziorek | C | -2.39 | 3 | +0.58 |
| @PortfolioBoss | C | -1.86 | 2 | +0.47 |
| @DivIncomeBcast | C | +0.27 | 1 | +0.45 |
| @MarketMaestro1 | C | -2.46 | 1 | +0.55 |
| @KunnuInvests | C | -1.52 | 1 | +0.70 |
| @hughesanalytics | A | -0.80 | 1 | +0.40 |
| @VladBastion | B | -1.80 | 1 | +0.35 |
| @ShakePryzby1 | B | +0.06 | 1 | +0.15 |
| @KeithTradeSmith | C | +0.25 | 1 | +0.55 |
| @MartyChargin | C | -0.27 | 1 | +0.40 |
| @PersimmonTI | A | -0.57 | 1 | +0.30 |
| @AsafNaamani | C | -3.38 | 1 | +0.35 |
| @BornInvestor | C | +0.16 | 1 | +0.15 |
| @SuEricGP | B | +2.07 | 1 | +0.70 |
| @MorningstarInc | B | +0.80 | 1 | -0.40 |
| @TalkMarkets | C | · | 1 | +0.00 |
Recent signals19of 19 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-28 | @TalkMarkets | +0.00 | Frames a valuation and growth-efficiency divergence between VRTX and REGN. | — | tweet ↗ |
| 2026-08-25 | @MorningstarInc | -0.40 | Morningstar analysts now rate VRTX and REGN as expensive and newly overvalued. | -2.0% | tweet ↗ |
| 2026-08-25 | @TravisBiziorek | +0.50 | Closed VRTX for a win while retaining substantial MRNA exposure and remaining bullish on VRTX. | -2.0% | tweet ↗ |
| 2026-08-25 | @SuEricGP | +0.70 | Recaps a 44% VRTX gain from $380 to $540 and says the rating is now hold. | -2.0% | tweet ↗ |
| 2026-08-23 | @BornInvestor | +0.15 | Historical recap of VRTX's 1999 catalyst, valuation peak, later trough and current market capitalization. | -1.2% | tweet ↗ |
| 2026-08-23 | @AsafNaamani | +0.35 | Reports ETF performance and identifies $40.48 as a breakout level for further upside. | -1.2% | tweet ↗ |
| 2026-08-23 | @PersimmonTI | +0.30 | Predicts BBIO could become the next VRTX if it remains independent. | -1.2% | tweet ↗ |
| 2026-08-23 | @MartyChargin | +0.40 | Enthusiastically frames four large drug companies as sector leaders. | -1.2% | tweet ↗ |
| 2026-08-23 | @KeithTradeSmith | +0.55 | Argues biotech is an underappreciated bull market supported by momentum, valuations and AI. | -1.2% | tweet ↗ |
| 2026-08-22 | @PortfolioBoss | +0.45 | Claims capital is flowing into Bitcoin and a broad pharmaceutical basket. | -1.2% | tweet ↗ |
| 2026-08-21 | @ShakePryzby1 | +0.15 | Sees a potential biotech leadership cycle and highlights CRSP as a breakout candidate. | -1.2% | tweet ↗ |
| 2026-08-21 | @TravisBiziorek | +0.80 | Buy VRTX; its weekly chart looks exceptionally strong. — Directly urges buying VRTX based on a strong weekly setup. | -1.2% | tweet ↗ |
| 2026-08-21 | @VladBastion | +0.35 | Ranks healthcare momentum leaders and highlights renewed interest in beaten-down CRL. | -1.2% | tweet ↗ |
| 2026-08-20 | @hughesanalytics | +0.40 | Identifies these symbols as strengthening while market rotation broadens beyond semiconductors. | +0.3% | tweet ↗ |
| 2026-08-19 | @TravisBiziorek | +0.45 | Reports VRTX achieving an all-time closing high. | -1.9% | tweet ↗ |
| 2026-08-19 | @KunnuInvests | +0.70 | Calls VRTX a strong monthly breakout after consolidation. | -1.9% | tweet ↗ |
| 2026-08-19 | @MarketMaestro1 | +0.55 | Monthly chart is described as positioned for a breakout. | -1.9% | tweet ↗ |
| 2026-08-18 | @PortfolioBoss | +0.50 | Calls a bull market and says capital is rotating into biotech. | +2.6% | tweet ↗ |
| 2026-08-18 | @DivIncomeBcast | +0.45 | Shares Grok's decade-long sector picks; ticker cap retains the first two baskets. | +2.6% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.